University of East Anglia Featured PhD Programmes
King’s College London Featured PhD Programmes
University of Nottingham Featured PhD Programmes
"antibodies"×
10 miles

antibodies PhD Projects, Programs & Scholarships

We have 28 antibodies PhD Projects, Programs & Scholarships

  • "antibodies" ×
  • clear all
Order by 
Showing 1 to 15 of 28
  Marie Curie Early Stage Researcher: Using Antibodies to Selectively Deliver Pairs of Mechanistically Complementary Drugs to Cancer Cells - Ref:1864950
  Prof V Chudasama
Application Deadline: 25 May 2020

Funding Type

PhD Type

Applications are invited for a 36-month PhD Studentship fully funded by the H2020 Marie Sklodowska-Curie Action and is available from June 2020.
  Developing new antibody-based therapeutics for neuroblastoma
  Prof A Sala
Applications accepted all year round

Funding Type

PhD Type

Metastatic neuroblastoma is a cancer of the nervous system that kills the majority of the affected children. Although there have been tremendous advances in the understanding of the molecular causes of the disease, patients are still treated with highly toxic mixtures of chemicals and radiation.
  Immunity to Influenza and Ebola viruses
  Prof A Townsend
Application Deadline: 24 July 2020

Funding Type

PhD Type

This started with the investigation of T cell recognition of peptides derived from intracellular proteins of Influenza (Townsend et al 1986), that evolved into the development of a live attenuated, single cycle Influenza vaccine, based on these principles (Powell et al, 2012; Baz et al, 2015, Holzer 2018).
  Development and Maturation of B cell Mediated Immune Responses
  Dr O Bannard
Application Deadline: 24 July 2020

Funding Type

PhD Type

We study the cellular interactions and molecular events that lead to the development of high affinity and protective antibodies during humoral immune responses.
  Immunity to Influenza and Ebola viruses
  Prof A Townsend
Application Deadline: 24 July 2020

Funding Type

PhD Type

This started with the investigation of T cell recognition of peptides derived from intracellular proteins of Influenza (Townsend et al 1986), that evolved into the development of a live attenuated, single cycle Influenza vaccine, based on these principles (Powell et al, 2012; Baz et al, 2015, Holzer 2018).
  Development of magnetic nanoparticles for improved targeted delivery of growth factors
  Dr V Chechik
Applications accepted all year round

Funding Type

PhD Type

Background. Magnetic nanoparticles (MNPs) can be heated by applying oscillating magnetic field. MNPs can hence be used to thermally destroy biological tissue (e.g., cancer cells) by remote magnetic activation.
  Development of novel antibody-nanoparticles conjugates (part of the ETN Targeted Anti-Cancer Therapies “TACT”)
  Research Group: Centre for Cancer Research and Cell Biology
  Prof C Scott, Dr K McCloskey
Application Deadline: 1 June 2020

Funding Type

PhD Type

Kadcyla® is an ADC that has been given FDA approval in early 2013 for the treatment of metastatic breast cancer. However, issues with the toxicity of the highly potent payload (e.g.
  MSc by Research Programme: Uncovering the role of Phosphorylated ubiquitin in health and disease
  Prof M Muqit
Application Deadline: 16 July 2020

Funding Type

PhD Type

This course allows you to work alongside our world renowned experts from the School of Life Sciences and gain a ’real research’ experience.
  Bioinspired filomicelles for the effective delivery of antibiotics
  Dr K Suntharalingam, Dr R Britton
Application Deadline: 7 June 2020

Funding Type

PhD Type

Background. Antibiotics are drugs that are used to prevent and treat bacterial infections. Antibiotic resistance occurs when bacteria modify their response to antibiotics, making them less effective or even redundant.
  Engineering Immune Cell Surfaces
  Prof I Gibson, Dr D Mitchell
Application Deadline: 7 June 2020

Funding Type

PhD Type

In the past decade there has been a revolution in therapeutics with protein and cell based therapies emerging to supplement traditional ‘small molecule’ drugs.
  Toward developing next-generation therapeutics - targeting the undruggable interactome
  Dr W Houssen, Prof M Jaspars, Dr L Trembleau
Applications accepted all year round

Funding Type

PhD Type

Cyclic and modified cyclic peptides are very appealing scaffolds especially as therapeutics with several examples reach the clinic e.g.
  Application of protein-drug conjugates for the treatment of cancer (part of the ETN Targeted Anti-Cancer Therapies “TACT”)
  Research Group: Centre for Cancer Research and Cell Biology
  Prof C Scott, Dr K McCloskey
Application Deadline: 1 June 2020

Funding Type

PhD Type

Macromolecular drug substances such as antibodies, ADCs and nanomedicine are often compromised in their therapeutic effectiveness due to inability to penetrate sufficiently into the diseased tissue and be taken up by the diseased cells.
  Development of small molecule inhibitors of FcεRI
  Prof D Cox, Dr M Adamo
Applications accepted all year round

Funding Type

PhD Type

Allergic diseases are one of the most common diseases in the Western world. A report from the American academy of allergy, asthma and immunology indicated that between 40-50% of children are sensitized to at least one allergen.
  Non-viral gene therapy to prevent cartilage degeneration in Osteoarthritis
  Dr C Curtain, Dr O Kennedy, Dr F O'Brien
Applications accepted all year round

Funding Type

PhD Type

Osteoarthritis (OA) is the most common form of joint disease, affecting one in five people in the EU and results in activity limitations for approximately one in ten.
  Optimisation and Preclinical Evaluation of Targeted Nanoformulations of Anti‐TNF‐α Therapeutics for the Treatment of Inflammatory Bowel Disease (IBD)
  Dr Z Ramtoola, Dr B Kirby
Applications accepted all year round

Funding Type

PhD Type

Inflammatory Bowel Disease (IBD) is a chronic inflammatory condition that affects the gastrointestinal tract (GIT) of the patient and comprises of Crohn’s disease (CD) and ulcerative colitis (UC).
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.